Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease

被引:1770
作者
Berger, EA [1 ]
Murphy, PM
Farber, JM
机构
[1] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA
[2] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA
[3] NIAID, Clin Invest Lab, NIH, Bethesda, MD 20892 USA
关键词
AIDS; genetics; G protein-coupled receptors; pathogenesis; therapeutics;
D O I
10.1146/annurev.immunol.17.1.657
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In addition to CD4, the human immunodeficiency virus (HIV) requires a coreceptor for entry into target cells. The chemokine receptors CXCR4 and CCR5, members of the G protein-coupled receptor superfamily, have been identified as the principal coreceptors for T cell line-tropic and macrophage-tropic HIV-1 isolates, respectively. The updated coreceptor repertoire includes numerous members, mostly chemokine receptors and related orphans. These discoveries provide a new framework for understanding critical features of the basic biology of HIV-1, including the selective tropism of individual viral variants for different CD4(+) target cells and the membrane fusion mechanism governing virus entry. The coreceptors also provide molecular perspectives on central puzzles of HIV-1 disease, including the selective transmission of macrophage-tropic variants, the appearance of T cell line-tropic variants in many infected persons during progression to AIDS, and differing susceptibilities of individuals to infection and disease progression. Genetic findings have yielded major insights into the in vivo roles of individual coreceptors and their ligands; of particular importance is the discovery of an inactivating mutation in the CCR5 gene which, in homozygous form, confers strong resistance to HIV-1 infection. Beyond providing new perspectives on fundamental aspects of HIV-1 transmission and pathogenesis, the coreceptors suggest new avenues for developing novel therapeutic and preventative strategies to combat the AIDS epidemic.
引用
收藏
页码:657 / 700
页数:44
相关论文
共 235 条
  • [121] Genetic acceleration of AIDS progression by a promoter variant of CCR5
    Martin, MP
    Dean, M
    Smith, MW
    Winkler, C
    Gerrard, B
    Michael, NL
    Lee, B
    Doms, RW
    Margolick, J
    Buchbinder, S
    Goedert, JJ
    O'Brien, TR
    Hilgartner, MW
    Vlahov, D
    O'Brien, SJ
    Carrington, M
    [J]. SCIENCE, 1998, 282 (5395) : 1907 - 1911
  • [122] Global distribution of the CCR5 gene 32-basepair deletion
    Martinson, JJ
    Chapman, NH
    Rees, DC
    Liu, YT
    Clegg, JB
    [J]. NATURE GENETICS, 1997, 16 (01) : 100 - 103
  • [123] The function of simian chemokine receptors in the replication of SIV
    Marx, PA
    Chen, ZW
    [J]. SEMINARS IN IMMUNOLOGY, 1998, 10 (03) : 215 - 223
  • [124] McCune J M, 1997, Semin Immunol, V9, P397, DOI 10.1006/smim.1997.0098
  • [125] CCR5 promoter polymorphism and HIV-1 disease progression
    McDermott, DH
    Zimmerman, PA
    Guignard, F
    Kleeberger, CA
    Leitman, SF
    Murphy, PM
    [J]. LANCET, 1998, 352 (9131) : 866 - 870
  • [126] Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent
    McKnight, A
    Wilkinson, D
    Simmons, G
    Talbot, S
    Picard, L
    Ahuja, M
    Marsh, M
    Hoxie, JA
    Clapham, PR
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (02) : 1692 - 1696
  • [127] A CXCR4/CD4 pseudotype rhabdovirus that selectively infects HIV-1 envelope protein-expressing cells
    Mebatsion, T
    Finke, S
    Weiland, F
    Conzelmann, KK
    [J]. CELL, 1997, 90 (05) : 841 - 847
  • [128] Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
    Mellors, JW
    Rinaldo, CR
    Gupta, P
    White, RM
    Todd, JA
    Kingsley, LA
    [J]. SCIENCE, 1996, 272 (5265) : 1167 - 1170
  • [129] Early protective effect of CCR-5 Delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load
    Meyer, L
    Magierowska, M
    Hubert, JB
    Rouzioux, C
    Deveau, C
    Sanson, F
    Debre, P
    Delfraissy, JF
    Theodorou, I
    Bary, M
    Burgard, M
    Dormont, J
    Boue, F
    Levy, A
    Dellamonica, P
    Perbost, I
    Carles, M
    Mondain, V
    Guillevin, L
    Jarousse, B
    Trogoff, B
    Lebras, P
    Goujard, C
    Quertainmont, Y
    Vilde, JL
    Leport, C
    Colassante, U
    Kazatchkine, M
    Vellay, A
    Buisson, M
    Cassuto, JP
    Reboulot, B
    Quaranta, M
    Sereni, D
    Gomez, V
    Bachmeyer, C
    Gallais, H
    Mars, ME
    Gallais, J
    Sobel, A
    Duval, J
    Majerhole, C
    Deforges, L
    Lefrere, JJ
    Lerable, J
    Joubert, L
    Dupont, B
    Beuzelin, C
    Fournier, S
    Vittecoq, D
    [J]. AIDS, 1997, 11 (11) : F73 - F78
  • [130] The role of CCR5 and CCR2 polymorphisms in HTV-1 transmission and disease progression
    Michael, NL
    Louie, LG
    Rohrbaugh, AL
    Schultz, KA
    Dayhoff, DE
    Wang, CE
    Sheppard, HW
    [J]. NATURE MEDICINE, 1997, 3 (10) : 1160 - 1162